Rebalix
Logo XtrackersXtrackers · sheet of 10 September 2026
ETF sheet · official issuer and register data

Xtrackers Usd High Yield Corporate Bond UCITS ETF 1c

XUHA · IE00BDR5HN05 · USD · domicile Ireland
Bonds · High yield USD · Broad (all maturities) · North AmericaSFDR art. 6 (inferred)
Index tracked: Bloomberg US High Yield Very Liquid Index ex 144A (USD)
TER
0.20%+ trans. 0.12%
Fund size
852 m EUR
Tracking difference
−0.27%3-year avg
🇮🇹 tax rate
25.97%white list 0.19%
Replication
Physical
Income
Accumulating
Duration
4.06 yrsmedium (3–7 years)
Launch 13 Dec 2021 · costs from the KID as of 2 Sept 2026 · 761 securities held · 5 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The fund is passively managed. INVESTMENT OBJECTIVE: The aim is for your investment to track the performance, before fees and expenses, of the Bloomberg US High Yield Very Liquid Index ex 144A (index). DESCRIPTION OF INDEX: The index is based on the Bloomberg US Corporate High Yield Index (Parent Index), which reflects the performance of high-yielding fixed-interest tradable debt (bonds) denominated in US Dollars. The index tracks a subset of bonds from the Parent Index which are readily realisable and includes bonds which are issued by financial,…

Performance since series start (in euro) — base 100

13 Dec 20218 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
2022202320242025202612093117
High 120 (10 Feb 2025) · low 93 (28 Jun 2022) · last 117. Past performance is not indicative of future results.

Returns in euro

1 year+5.4%
3 years+17.6%
5 yearsseries too young
10 yearsseries too young
Since series start+17.2%

Risk · 1 / 3 / 5 years

Volatility (ann.)2.74%3.55%
Max drawdown−2.30%−3.79%
Sharpe0.821.38
Sortino1.202.09
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · XUHA · IE00BDR5HN051
RebalixXUHA · IE00BDR5HN05 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+9.09%+9.16%−0.07%
2024+7.17%+7.50%−0.33%
2023+13.47%+13.87%−0.40%
2022−12.05%−12.02%−0.03%

Fixed income — as declared by the issuer

Issuer page · 20 Aug 2026
Maturity breakdown (% of fund)
< 1 year0.1%1–3 years14.1%3–5 years35.4%5–7 years31.2%7–10 years15.8%10–15 years0.3%25+ years3.1%

Holdings

Portfolio as declared by the issuer · 2 Sept 2026 · 761 securities · top-10 weight = 5.9%
Countries (% of fund)
United States88.1%Canada3.5%United Kingdom1.8%Luxembourg1.3%Ireland0.9%

Listing venues

ESMA register (FIRDS) and official exchange lists
XUHA · Börse Düsseldorf, Börse Hamburg, Börse Hannover, Börse München / gettex, Tradegate Exchange
+ 6 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · etf.dws.com/download/asset/2bc55e5d-ac06-472d-a467-9d468947c1a7
Factsheet · etf.dws.com/download/asset/44b22f03-3206-49e0-8cc2-887a39244866
Prospectus · etf.dws.com/download/asset/25f159fa-a123-4a77-9751-682976c15095
The live sheet, always up to date
rebalix.com/en/etf/IE00BDR5HN05
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · XUHA · IE00BDR5HN052